in unstimulated cardiac muscle. Abstract We examined the effect of several nitric oxide (NO) donors, authentic NO gas, and L-arginine in isolated cat and rat papillary muscles. We did not observe significant inotropic effects in response to any NO donor (ie, SPM-5185, C87-3754, and S-nitroso-N-acetylpenicillamine [SNAP]) from 1 nmol/L to 100 ,umol/L. Similarly, authentic NO, at concentrations far in excess of those that maximally dilate the coronary vasculature (ie, 500 nmol/L), also failed to exert a detectable inotropic effect in these preparations. However, in the presence of 5 ,umol/L norepinephrine, 500 nmol/L NO exerted a 12±3% decrease in isolated rat papillary muscle contractility (P<.05). Addition of L-arginine up to 25 mmol/L exerted no inotropic effects in isolated rat papillary muscles. However, at 50 mmol/L, L-arginine decreased contractile force by 21±4% (P<.01). On further examination, the negative inotropic effect of 50 mmol/L L-arginine appeared to be nonspecific, since the inactive stereoisomer, D-arginine, at 50 mmol/L exerted the same effect. Further studies in isolated
itric oxide synthase (NOS) exists in several N isoforms, all of which use L-arginine as the substrate to produce nitric oxide (NO).12 Endothelium-derived NO is synthesized by a constitutive NOS and is critical for the preservation of vascular homeostasis. 1, 3 The constitutive NO synthase is associated with low levels of NO formation, which are continuously generated (ie, basal production).4 Despite these modest levels of NO production, NO released via the constitutive pathway is sufficient to maintain vascular tone and inhibit neutrophil and platelet adhesion to the vascular endothelium under control conditions.56 These physiological concentrations apparently are between 0.1 and 1 nmol/L in the coronary circulation. 7 Similarly, therapeutic concentrations (ie, -500 nmol/L) of agents that release physiological concentrations of NO (ie, NO donors) also inhibit neutrophil and platelet adhesion to endothelial cells and preserve the ischemic/reperfused myocardium.8-10 Although low concentrations of NO clearly have cardioprotective effects adult rat cardiac myocytes elicited similar results, in that 50 mmol/L of L-and D-arginine equally decreased contraction amplitude and the underlying cytosolic calcium transient. Moreover, 500 nmol/L of the NO donor SPM-5185 only modestly decreased contraction amplitude or intracellular calcium in isolated rat cardiac myocytes. These results indicate that administration of physiological concentrations of exogenous NO does not acutely depress the inotropic state of the rat or cat heart to a physiologically significant extent. Only in the presence of high concentrations of norepinephrine did NO exert a statistically significant negative inotropic effect, and this effect was a modest one. These data demonstrate that physiological levels of NO do not exert a major regulatory effect on cardiac contractility. (Circ Res. 1994 ;75:692-700.)
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Another form of NOS, known as inducible NOS, can be activated by cytokines and endotoxin. Its expression peaks after 6 to 12 hours in various cell types (eg, macrophages and vascular smooth muscle)."1-13 Al- though direct measurements of endogenous NO are still not available because of its short half-life in vivo, indirect measurements indicate that NO is produced at significantly higher levels via the inducible NOS pathway. 4 These high concentrations of NO are thought to depress cardiac contractility during the late stages of septic shock.14 NG-Nitro-L-arginine methyl ester (L-NAME) and NG-monomethyl-L-arginine (L-NMMA), two NOS inhibitors, do not directly alter myocyte contractility, indicating that cardiac myocytes do not synthesize appreciable amounts of constitutive NO in their normal state.11'14-17 However, Finkel et al18 reported that tumor necrosis factor-a (TNF-a) depressed contractility of isolated papillary muscles within 3 to 5 minutes, an effect that could be reversed by L-NMMA. Since L-arginine reversed the effects of L-NMMA, the authors speculated that the acute negative inotropic effects of TNF-a were elicited by a constitutive NOS. However, these studies do not conclusively prove whether NO released via the constitutive NOS pathway is sufficient to acutely depress cardiac contractility. More 4 .7% of resting cell length) in the presence of 10 ,umol/L sodium nitroprusside. However, no one has compared physiological amounts of NO in these diverse preparations and compared them with effects on vascular smooth muscle.
In view of these uncertainties and unresolved questions, we examined the inotropic effects of authentic NO, newly developed organic NO donors that release NO without the need for metabolic transformation by smooth muscle cells, and the precursor of endogenous NO synthesis (ie, L-arginine) on cardiac contractility in rat and cat myocardium in preparations ranging from isolated cardiac myocytes to isolated papillary muscles and compared their effects in vascular smooth muscle preparations isolated from the same animal.
Materials and Methods

Isolated Cat Coronary Artery Ring Studies
Adult male cats (2.5 to 4.0 kg) were anesthetized with sodium pentobarbital (30 mg/kg IV). After a midsternal thoracotomy, the heart was quickly removed and placed into Krebs-Henseleit (K-H) solution consisting of (mmol/L) NaCl 118, KCl 4.75, CaCl2* 2H20 2.54, KH2PO4 1.19, MgSO4* 7H20 1.19, NaHCO3 12.5, and glucose 10.0. Both left anterior descending coronary artery and left circumflex coronary artery segments (internal diameter, 0.3 to 0.5 mm) were dissected, cleaned of fat and connective tissue, and carefully cut into rings 2 to 3 mm in length. The rings were then mounted on stainless-steel hooks, suspended in 7-mL tissue baths, and subsequently connected to Grass FT-03 force displacement transducers to record changes in force by using a Grass model 7 oscillographic recorder (Grass Instrument Co). The baths were filled with 7 mL K-H solution and aerated at 37°C with a gas mixture of 95%O 2/5% C02. Coronary rings were initially stretched to give a preload of 0.5 g of force and equilibrated for 90 minutes. During this period, the K-H solution in the tissue baths was replaced every 20 minutes. After equilibration, the rings were then precontracted by 100 nmol/L U-46619 (9,11-epoxymethano-prostaglandin H2), a thromboxane A2 mimetic, to generate ::=0.5 g of developed force. Once a stable contraction was obtained, either S-nitroso-N-acetylpenicillamine (SNAP), a nitrosothiol NO donor, SPM-5185 [N-nitratopivaloyl-S-(N'-acetylalanyl)-cysteine ethyl ester], a cysteine-containing NO donor, or C87-3754 (3-[1-(2,6-dimethylpiperidino)]-sydnonimine-hydrochloride-hydrate), a sydnonimine NO donor, was separately added to the bath cumulatively (SNAP, 1, 2.5, 5, 10, 25, 50, and 250 nmol/L; SPM-5185 and C87-3754, 1, 2.5, 5, 10, and 50 gmol/L). Relaxation responses were expressed as a percentage of the U-46619-induced contraction.
Authentic NO was bubbled for 1 hour from a gas cylinder containing 1% NO/99% N2 into O2-purged distilled water or K-H solution in a specially designed airtight chamber. Just before addition, the NO solution was withdrawn from the bubbling chamber into an airtight glass syringe. The solution was then added to the 7-mL vascular ring bath at volumes of 0.1 to 0.3 mL; measured NO concentrations in the baths were 160 to 500 nmol/L, respectively, with these NO additions. Vasorelaxation responses of coronary artery rings to NO solution were assessed as described above.
Isolated Cat Papillary Muscles
Adult male cats (2.5 to 4.0 kg) were anesthetized with sodium pentobarbital, and their hearts were quickly excised. Papillary muscles <1.5 mm in diameter were dissected from the right ventricle in warmed oxygenated K-H solution, and a 4-0 silk suture was tied to each end. The preparations were suspended individually in the tissue chambers and subsequently connected to Grass FI'-03 force displacement transducers to record changes in force with a Grass model 7 oscillographic recorder. Each muscle was stretched to the length at which contractile force was maximal (preload, 1.0 to 2.0 g). The preparations were electrically paced at 1 Hz with pulses of 5-millisecond duration at a voltage "~'50% greater than threshold. All preparations were allowed to equilibrate in drug-free K-H solution for 40 to 60 minutes until complete mechanical stabilization had been achieved. All NO-donating compounds were freshly dissolved in prewarmed and preaerated K-H solution and cumulatively added to the bath chambers. Fresh NO in K-H solution (0.1 to 0.6 mL) was added to a 7-mL tissue bath cumulatively. Measured NO concentrations in the bath were 160 to 960 nmol/L. After each observation, muscles were washed several times and allowed to recover for 10 to 20 minutes until their mechanical function completely returned to control values.
Isolated Rat Papillary Muscles and
Rat Aortic Rings
Male Wistar rats (250 to 300 g) were anesthetized with sodium pentobarbital (50 mg/kg), and their hearts were quickly excised. Papillary muscles <1 mm in diameter were dissected from the left ventricle in oxygenated K-H solution, and their mechanical response to authentic NO, NO donors, arginine, and aspartic acid was studied as described above for cat papillary muscles. The pH of the 50-mmol/L L-arginine and D-arginine solutions was found to be 9.74±0.15 and 9.66±0.13, respectively. In some experiments, NO gas was added to papillary muscles in the presence of 10 nmol/L to S gmol/L norepinephrine.
Rat aortic rings were isolated from the same rats as those in which the papillary muscles were obtained. The aorta was trimmed of fat and connective tissue and cut into rings of 2 to 3 mm. The rings were mounted in 7-mL tissue baths as described above for the cat coronary arteries. After equilibration for 90 minutes in K-H solution, the aortic rings were precontracted with 5 ,umol/L norepinephrine bitartrate (Sterling-Winthrop). After 10 to 15 minutes, developed force stabilized, and NO gas could be added to the bath under control conditions or under conditions of enhanced constrictor tone in response to 5 ,umol/L norepinephrine.
Measurement of NO Concentrations
NO was measured using an ISO-NO meter obtained from World Precision Instruments, Inc. This NO meter was connected to a polarographic NO electrode described by Shibuki and Okada. 19 The current flow across this electrode is proportional to the NO concentration at the surface of the membrane on the electrode. Calibration and amperometric measurements were made according to the methods of Tsukahara et a120 and recorded on a strip-chart recorder (BD 40, Kipp and Zonen). All values reported were means of at least six measurements reported as nanomolar NO concentrations.
Isolated Rat Cardiac Myocytes
Ca2+-tolerant quiescent cardiomyocytes were isolated from the hearts of adult male Sprague-Dawley rats (350 to 400 g) by retrograde aortic collagenase perfusion as described previously. 20 The cells were finally resuspended at a concentration of 5 mg cell protein per milliliter in incubation buffer composed of (mmol/L) NaCl 121, HEPES 10, NaHCO3 5, KCl 4. To determine whether this lack of inotropic effect of NO solution or NO donors on papillary muscles was due to a peculiarity of cat cardiac muscle, we observed their inotropic effect in isolated rat papillary muscles. ,.mol/L pentobarbital. These results indicate that the lack of the inotropic responses to NO is not specific for cat cardiac muscle.
To clarify whether addition of the substrate for NOS enhances endogenous NO production and thus may exert inotropic activity, we studied the effect of L-arginine, the precursor of endogenous NO L-arginine, rat papillary muscle contractions decreased to 21+4% of the control value (Fig 4) . Surprisingly, addition of D-arginine, the inactive stereoisomer of L-arginine that does not generate NO, also exerted the same negative inotropic effects as observed with L-arginine (Fig 4) . Moreover, the L-arginine-induced negative inotropic effect could not be blocked by either L-NMMA at concentrations up to 25 mmol/L (Fig 4) or L-NAME, another NOS inhibitor, at concentrations up to 50 mmol/L. The contractile force at 50 mmol/L L-arginine decreased 21±4% and 23±3% in the presence and absence of 50 mmol/L L-NAME, respectively. These values are not significantly different from each other. Therefore, the inotropic effect of L-arginine does not appear to be related to NO generation, since L-NMMA or L-NAME could not block this effect and D-arginine exerted the same inotropic effect as L-arginine.
We examined the effect of NO gas on norepinephrine-stimulated aortic rings and papillary muscles isolated from the same rats. Norepinephrine (5 ,umol/L) significantly increased contractile force in the papillary muscle and increased tone in the aortic rings. NO was added to the baths and was measured by using the (Fig 6, bottom panel) . In agreement with the lack of effect on contraction, SPM-5267 had no effect on the Ca2+ transient. For the group of cardiomyocytes treated with SPM-5185, the reduced amplitude of the Ca2+ transient was highly correlated with the depression of cell contractility with a slope of 0.828 (r=.923, P<.001). The effects of L-and D-arginine on Ca2+ and contraction were less well correlated (r=.791 and .790, respectively), and the slopes of these relations were much less steep (0.445 and 0.371, respectively). Taken together with the differential effects of the two arginine isomers on the kinetics of Ca 2+ and contraction, these data suggest that high levels of arginine may influence cardiomyocyte contraction through a second mechanism in addition to the inhibition of the Ca2+ transient.
In an additional series of isolated rat cardiomyocytes, we stimulated the cells with 1 ,umol/L norepinephrine. Five rat cardiomyocytes shortened 2.8+0.4% of resting cell length under control conditions. In the presence of 1 gmol/L norepinephrine, these five myocytes shortened 15 .2+0.6% (P<.01). However, when 10 ,umol/L SPM-5185 was added together with the 1 ,umol/L norepinephrine, the degree of shortening was 16.1+0.6%, a value not significantly different from norepinephrine alone. Similarly, the intracellular Ca2+ transient amplitude increased from 151 + 10 nmol/L under resting conditions to 679±46 nmol/L on stimulation with 1 gamol/L norepinephrine (P<.01). When 10 ,umol/L SPM-5185 was added in the presence of norepinephrine, the Ca2' transient was 704±45 nmol/L, a value not significantly different from the value obtained with norepinephrine alone. These data indicate that even under norepinephrine stimulation, high concentrations of an NO donor were ineffective in exerting a significant negative inotropic effect.
Discussion
NO is an important messenger that regulates physiological processes throughout the cardiovascular system. The goal of the present study was to determine the effect of physiological concentrations of NO, which would most likely be produced via the constitutive NOS pathway. We administered these therapeutic concentrations to isolated papillary muscles and to isolated individual cardiac myocytes in order to study myocardial contractility under different levels of organization.
Very few studies exist of the inotropic effects of NO in vivo. Lefer et To rule out the possibility that NO delivered via the coronary circulation may not reach cardiac myocytes at concentrations high enough to exert inotropic effects and to exclude indirect changes in cardiac contractility induced by NO due to its vasodilator properties,26 we studied the direct effect of NO donors and authentic NO on ventricular papillary muscle contractility. The NO donors studied (SNAP, SPM-5185, and C87-3754) all readily release NO in vitro without the need for cellular metabolism.27 This release of NO was confirmed, since these agents relaxed coronary artery rings completely (Fig 1) ,umol/L sodium nitroprusside induced early relaxation and decreased peak twitch in a similar preparation of isolated cat papillary muscles. Although the apparent differences between their study and our present findings are not clear, the total reduction in peak tension reported by Meulemans et al was very small, -3% to 5%. It is unlikely that these small decreases in contractility would have an appreciable effect on cardiac output or cardiac contractility in vivo.
To assess whether endogenous NO release exerts similar effects on cardiac contractility when compared with exogenous NO administration, we administered L-arginine, the precursor of NO synthesis, to rat papillary muscles. We found that concentrations of L-arginine up to 10 mmol/L had no significant effect on papillary muscle contractility. However, at 50 mmol/L, L-arginine exerted a significant negative inotropic effect similar to that reported by Finkel et al, 18 who also found that 50 to 100 mmol/L L-arginine exerted a negative inotropic effect in hamster papillary muscle. However, on further examination, we found that the negative inotropic effect elicited by these extremely high concentrations of L-arginine was not related to NO generation, since D-arginine, the inactive stereoisomer of L-arginine, also induced a similar negative inotropic effect in rat papillary muscles. Moreover, the negative inotropic effect elicited by high concentrations of L-arginine could not be reversed by L-NMMA or L-NAME, two NOS inhibitors. Since In the present study, we found that L-arginine, the substrate for endogenous NO synthesis, does not significantly decrease myocyte contraction amplitude or intracellular Ca 2 fluxes at concentrations up to 10 mmol/L. In contrast, 50 mmol/L L-arginine depressed myocyte contraction amplitude and significantly decreased intracellular Ca2. However, the same negative inotropic effect also occurred in response to D-arginine, indicating that the negative inotropic effect elicited by 50 mmol/L L-arginine is not related to NO generation. The nonspecific effect of high concentrations of L-arginine (ie, 50 to 100 mmol/L) on cardiac myocytes directly coincides with its nonspecific effect on isolated papillary muscles. The inability of L-arginine to elicit negative inotropic effects through NO generation is not surprising, since the availability of L-arginine in normal states is not rate limiting in the synthesis of NO.29 Moreover, other investigators have shown that NOS inhibitors, particularly L-NMMA and L-NAME, do not alter basal contractility in isolated cardiac myocytes.1"14-17 These results, in conjunction with previous studies, demonstrate that endogenous NO released via the constitutive pathway does not elicit significant acute negative inotropic effects.
In summary, our results indicate that physiologically relevant concentrations of NO do not induce physiologically significant negative inotropic effects acutely in two different mammalian species in which we investigated the inotropic effect of NO on cardiac muscles at two different levels of organization (ie, isolated cardiac myocytes and isolated ventricular papillary muscles). The only condition in which a significant, albeit small, negative inotropic effect occurred is under the influence of high concentrations of norepinephrine. These results provide substantial evidence that low levels of NO, which inhibit neutrophil and platelet adhesion as well as maintain basal vascular tone, do not exert a major effect on cardiac contractility. If anything, abolition of endogenous NO reduces myocardial contractility in the conscious dog.24 Moreover, a recent study indicates that NO does not exert a significant negative chronotropic effect in isolated rat atrial preparations.30
